Journal of Applied Corporate Finance

1989 - 2018

Current editor(s): Donald H. Chew Jr.

From Morgan Stanley
Bibliographic data for series maintained by Wiley Content Delivery ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 30, issue 3, 2018

A Message from the Editor pp. 2-3

John McCormack

The Dynamism of Nations: Toward a Theory of Indigenous Innovation pp. 8-26

Edmund Phelps

Management's Key Responsibility pp. 27-35

Bartley J. Madden

Funding Strategies in a Rising Interest Rate and a Flattening Yield Curve Environment pp. 36-46

Niso Abuaf

Financing Urban Revitalization: A Pro‐Growth Template pp. 47-54

Steve H. Hanke and Stephen J.K. Walters

A review of Buffett's commentary on accounting, governance, and investing practices: does he “walk the talk”? pp. 55-75

Robert M. Bowen, Shivaram Rajgopal and Mohan Venkatachalam

Volume 30, issue 2, 2018

Investors as Stewards of the Commons? pp. 8-17

George Serafeim

Rethinking the Purpose of the Corporation pp. 18-21

Edward J. Waitzer

The ESG Integration Paradox pp. 22-28

Michael Cappucci

Building a Bridge between Marketing and Finance pp. 29-39

Ryan Barker and Greg Milano

“Big Data” Analysis: Putting the Data Cart Before the Modelling Horse? pp. 40-44

Graham D. Barr, Theodor J. Stewart and Brian S. Kantor

Debt Crisis Looming? Yes, Corporate Debt Expanded but Don't Panic Over the Prospect of BBB Downgrades pp. 45-49

Martin Fridson

Buyout Transactions in the German‐speaking Region: Determinants of Abnormal Performance and Unlevered Returns pp. 50-64

Fabian Söffge and Reiner Braun

Processes and Accuracy of Cash Flow Forecasting: A Case Study of a Multinational Corporation pp. 65-82

Martin Glaum, Peter Schmidt and Kati Schnürer

An Empirical Study of Insurance Performance Measure pp. 83-91

Sai Ranjani Bharathkumar

Valuation of Corporate Innovation and the Pricing of Risk in the Biopharmaceutical Industry: The Case of Gilead pp. 92-108

Richard Ebil Ottoo

Volume 30, issue 1, 2018

Eclipse of the Public Corporation or Eclipse of the Public Markets? pp. 8-16

Craig Doidge, Kathleen M. Kahle, G. Andrew Karolyi and René M. Stulz

Fiduciary Duties of Corporate Directors in Uncertain Times pp. 17-22

Ira M. Millstein, Ellen J. Odoner and Aabha Sharma

Financial Flexibility and Opportunity Capture: Bridging the Gap Between Finance and Strategy pp. 23-29

Stephen V. Arbogast and Praveen Kumar

Say on Pay: Is It Needed? Does It Work? pp. 30-38

Stephen F. O'Byrne

Internal Governance Does Matter to Equity Returns but Much More So During “Flights to Quality†pp. 39-52

Peter G. Brooke, Paul Docherty, Jim Psaros and Michael Seamer

Clawbacks, Holdbacks, and CEO Contracting pp. 53-61

Stuart L. Gillan and Nga Q. Nguyen

Fundamental Investors Reduce the Distraction on Management from Random Market “Noiseâ€: Evidence from France pp. 62-69

Alexandre Garel and Jean†Florent Rérolle

An Improved Method for Valuing Mature Companies and Estimating Terminal Value pp. 70-77

David A. Holland

Biomarker of Quality? Venture†backed Biotech IPOs and Insider Participation pp. 78-88

Hans Jeppsson

How to Evaluate Risk Management Units in Financial Institutions? pp. 89-97

Michael Gelman, Doron Greenberg and Mosi Rosenboim

Global Trade – Hostage to the Volatile US Dollar pp. 98-105

Brian Kantor

Corporate Finance and Sustainability: the Case of the Electric Utility Industry pp. 106-111

Steven Kihm, Peter Cappers, Andrew Satchwell and Elisabeth Graffy

Volume 29, issue 4, 2017

Has Financial Regulation Been a Flop? (or How to Reform Dodd†Frank) pp. 8-24

Charles W. Calomiris

Statement of the Financial Economists Roundtable: Bank Capital as a Substitute for Prudential Regulation pp. 25-29

Charles W. Calomiris, Larry Harris, Catherine Schrand and Roman L. Weil

High†Frequency Trading and the New Stock Market: Sense And Nonsense pp. 30-44

Merritt B. Fox, Lawrence R. Glosten and Gabriel V. Rauterberg

Shadow Banking, Risk Transfer, and Financial Stability pp. 45-64

Christopher L. Culp and Andrea M. P. Neves

Why European Banks Are Undercapitalized and What Should Be Done About It pp. 65-71

John D. Finnerty and Laura Gonzalez

Leverage and Taxes: Evidence from the Real Estate Industry pp. 86-95

Michael J. Barclay, Shane M. Heitzman and Clifford W. Smith

Formulaic Transparency: The Hidden Enabler of Exceptional U.S. Securitization pp. 96-111

Amar Bhidé

How Investment Opportunities Affect Optimal Capital Structure pp. 112-124

Stanley Myint, Antonio Lupi and Dimitrios P. Tsomocos

How to Integrate ESG into Investment Decision†Making: Results of a Global Survey of Institutional Investors pp. 125-133

Robert G. Eccles, Mirtha D. Kastrapeli and Stephanie J. Potter

Maximum Withdrawal Rates: A Novel and Useful Tool pp. 134-137

Javier Estrada

Volume 29, issue 3, 2017

The Evolving Shareholder Activist Landscape (How Companies Can Prepare for It) pp. 8-17

Ajay Khorana, Anil Shivdasani and Gustav Sigurdsson

Improving the Health of Healthcare Companies pp. 18-29

Gregory V. Milano, Marwaan R. Karame and Joseph G. Theriault

University of Texas Roundtable on The State of the U.S. Private Equity Market pp. 30-41

Andy Jhawar, Tiffany Kosch, Austin Long and Will Carpenter

University of Texas Roundtable on The Role of Private Equity in the Financing and Restructuring of Oil and Gas Companies pp. 42-53

Bryan Sheffield, Bill Montgomery, Jim Hackett and Chris Manning

The Keys to Success in Spinoffs pp. 54-64

Craig Emrick, Ajay Khorana, Anil Shivdasani and Peter Ventouras

Statement of the Financial Economists Roundtable: Corporate Tax Reform pp. 65-70

Arnoud Boot, Dennis Logue and Chester Spatt

Two Different Ways of Treating Corporate Cash in FCF Valuations—and the Importance of Getting the Cost of Capital Right pp. 71-79

Peter D. Easton and Gregory A. Sommers

Valuation of a Pharmaceutical Licensing Contract pp. 80-88

John Lynch and Richard Shockley

Investor Protection and Governance in the Valuation of Emerging Markets Investments pp. 89-100

Leila Atwi, Assem Safieddine and Sheridan Titman

The Empirical Average Cost of Capital: A New Approach to Estimating the Cost of Corporate Funds pp. 101-110

Gerard T. Olson and Michael S. Pagano

Volume 29, issue 2, 2017

How We Invest pp. 10-15

Michael Bloomberg and Carl Pope

Sustainability and Rewriting the Book on Valuation: An Interview with Tim Koller pp. 16-20

Jonathan Bailey and Tim Koller

The SEC and Improving Sustainability Reporting pp. 22-31

Keith Higgins, John White, Alan Beller and Mary Schapiro

The Next Wave of ESG Integration: Lessons from Institutional Investors pp. 32-43

Chris Ailman, Michelle Edkins, Kristi Mitchem, Ted Eliopoulos and Janine Guillot

Analysts' Roundtable on Integrating ESG into Investment Decision-Making pp. 44-55

Dan Hanson, Tom Lyons, Jennifer Bender, Bruno Bertocci and Bobby Lamy

Far Beyond the Quarterly Call: CECP's First CEO-Investor Forum pp. 56-69

Tim Youmans and Brian Tomlinson

Evaluating Sustainable Competitive Advantage pp. 70-75

Baruch Lev

The Purpose of the Firm, Valuation, and the Management of Intangibles pp. 76-86

Bartley J. Madden

Investing in the UN Sustainable Development Goals: Opportunities for Companies and Investors pp. 87-99

Willem Schramade

Evaluating the Effectiveness of Sustainability Disclosure: Findings from a Recent SASB Study pp. 100-108

Arturo Rodriguez, Henrik Cotran and Levi S. Stewart

Lies, Damn Lies, and Statistics: Why a Widely Used Sustainability Metric Fails and How to Improve It pp. 109-114

Jon Bartley, Al Chen, Stephen Harvey, Scott Showalter, Gilroy Zuckerman and Levi Stewart

Volume 29, issue 1, 2017

The Case for Activist Directors: A Conversation with Ira M. Millstein pp. 10-14

Ira M. Millstein and Geoff Colvin

Crises, Financial Leadership, and the Six Stretches for Financial Education pp. 15-21

Robert F. Bruner

The Role of Corporate Boards: A Roundtable Discussion of Where We're Going and Where We've Been pp. 22-35

Jesse Greene, Raj Gupta, Sophie L'Helias and Bill McCracken

The Evolution of Executive Pay Policy at General Motors, 1918–2008 pp. 36-49

Stephen F. O'Byrne and S. David Young

FMA Roundtable on New Developments in European Corporate Governance pp. 50-75

Charles Elson, Tom Berglund, Marc Steffen Rapp, Wolfgang Bessler and Don Chew

Columbia Law School Roundtable on A Governance Research Agenda for the Academy pp. 76-85

Martijn Cremers, Vik Khanna and Jeff Gordon

Liquefying a Market: The Transition of LNG to a Traded Commodity pp. 86-92

Craig Pirrong

Separating Leadership from Pay pp. 93-98

Stephan Hostettler and Raphaël Lambin

Corporate Governance and the Investment Efficiency of Diversified Corporate Asset Buyers pp. 99-114

I-Ju Chen and Sheng-Syan Chen

IPO or SBO?: The Increasing Importance of Operational Performance for Private Equity Exits Following the Global Financial Crisis of 2007–08 pp. 115-121

Emil Plagborg-Møller and Morten Holm